Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Urologic Oncology|April 15, 2004
Relationship of body mass index and prostate specific antigen in a population-based studyIan M Thompson, Robin Leach, Dean Troyer, et al.The Urologic Clinics of North America|May 9, 2003
Chemoprevention of prostate cancer. Focus on key opportunities and clinical trialsRobin Leach, Brad Pollock, Joseph Basler, et al.Urologic Oncology|April 10, 2003
Challenges and opportunities to the design and implementation of chemoprevention trials for prostate cancerIan M Thompson, Joseph A Basler, Robin Leach, et al.The Journal of Biological Chemistry|August 10, 2006
Cloning and characterization of the annexin II receptor on human marrow stromal cellsGanwei Lu, Hidefumi Maeda, Sakamuri V Reddy, et al.Journal of the International Neuropsychological Society : JINS|October 11, 2005
Cognitive ability predicts degree of genetic abnormality in participants with 18q deletionsMargaret Semrud-Clikeman, Nora M Thompson, Becky L Schaub, et al.Urology|May 10, 2011
Trends and co-trends of prostate-specific antigen and body mass index in a screened populationDonna P Ankerst, Brad H Pollock, Yuanyuan Liang, et al.Clinical Prostate Cancer|March 26, 2004
Prostate cancer prevention: what do we know now and when will we know more?Ian M Thompson, Joseph Basler, Deborah Hensley, et al.Cancer Management and Research|June 30, 2026
Combining Serum PVT1 Exon 4A and Exon 9 with Serum Prostate-Specific Antigen Shows Potential for Improving Identification and Risk Stratification of Prostate CancerEmmanuel Asante-Asamani, Rachel E Bonacci, Tinovimba Hove, et al.The Prostate|February 26, 2023
Prevalence of genotoxic bacteria in men undergoing biopsy for prostate cancerJohn Lee, Brian L Wickes, Jianmin Fu, et al.European Urology|July 16, 2018
Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate CancerMichael A Liss, James Robert White, Martin Goros, et al.Pageof 2